$0.6332
0.003200.51%
At close: -
$0.6205
-0.01-2.01%
After Hours: Feb 14, 7:53 PM EDT
Comments
Loading...
Bio-Path Hldgs (BPTH) Forecast
NewsEarningsBio-Path Hldgs (BPTH) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBio-Path Hldgs (NASDAQ:BPTH) Stock Quotes, Forecast and News Summary
Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Path Hldgs (BPTH) stock?
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Who are Bio-Path Hldgs (BPTH) competitors?
Other companies in Bio-Path Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for Bio-Path Hldgs (BPTH) stock?
Bio-Path Hldgs has a consensus price target of $23.00.
What is the current price for Bio-Path Hldgs (BPTH)?
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $0.6205 last updated February 14, 2025 at 7:53 PM EST.
Does Bio-Path Hldgs (BPTH) pay a dividend?
There are no upcoming dividends for Bio-Path Hldgs.
When is Bio-Path Hldgs (NASDAQ:BPTH) reporting earnings?
Bio-Path Hldgs’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Bio-Path Hldgs (BPTH) going to split?
There is no upcoming split for Bio-Path Hldgs.
What sector and industry does Bio-Path Hldgs (BPTH) operate in?
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.